Related Experiment Videos
Aromatase inhibitors in breast cancer: current and evolving roles
1Department of Hematology and Medical Oncology, The Cleveland Clinic Foundation, OH 44195, USA.
Cleveland Clinic Journal of Medicine
|July 12, 2002
Abstract:
The aromatase inhibitors are established first-line drugs for treating metastatic breast cancer in postmenopausal women, and are gaining acceptance as adjuvant treatment as well.